Loading…
Astronics Corporation
🏹 Trader: 📈 Stage 2 | BRS 64 Forming View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$3.4B
Market Cap
67.0
P/E
1.21
PEG
14.9%
ROCE
14.8%
ROE
2.66
D/E
8.9%
OPM
-17.1%
% from 52W High
92
α RS
🔍 ATRO is showing a momentum setup because RS Rating is 92 (top decile vs market), it's within 17.1% of its 52-week high, and it's hugging the 21 EMA. Net: Broad signal stack, not a recommendation. ? RS Rating 52W High Technicals
Sources
RS Rating 92 · 17.1% from 52W high · hugging 21 EMA
🌏 Global Investor Returns
Currency-adjusted total returns for ATRO including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace, defense, and electronics industries in the United States, rest of North America, Asia, Europe, South America, and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding ATRO
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 567.2K $37.9M 0.05% Mar 2026
Jim Simons Renaissance Technologies LLC 222.9K $14.9M 0.02% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific ↑ Improving 4 quarters Full tone analysis in Intelligence →
📊 MIXED Astronics Q1 2026: Record bookings $290M, revenue $230M, raised guidance to $970M-$1B
Revenue & Profitability
Q1 2026 revenue was $230M (12% YoY growth). Net income $25.5M ($0.67 diluted EPS) vs $9.5M ($0.26) a year ago. Adjusted EBITDA $37.9M (16.4% margin). Operating income $27.2M more than doubled from $13.1M. Record bookings of $290M and backlog of $734M.
Outlook
Management sees strong demand from rising commercial aircraft production rates (Airbus/Boeing planning 30-50% rate increases) and the trend of passengers demanding connectivity and power. No impact from the Iran War has been seen. Revenue guidance raised to $970M-$1B for 2026, assuming 14-16% organic growth.
Growth Drivers
Key growth levers: IFEC demand (half of sales), Seat Motion (sales tripled YoY to $13.2M, expected >100% growth in 2026), Flight-Critical Electrical Power (10% of sales, strong on MV-75 and eVTOL), and test systems (Army Radio Test Program expected to contribute ~$20M in H2 2026). General aviation IFEC sales up 40.7%.
Balance Sheet & CapEx
Q1 2026 CapEx was $11.2M (vs $2.1M a year ago) driven by capacity expansion and facility consolidation in Seattle. Full-year 2026 CapEx guidance is $40-45M. Additionally, $15-17M is expected to be invested in a new global ERP system ($2-3M expensed, remainder capitalized) over the year.
Margins
Adjusted EBITDA margin improved to 16.4% from 14.9% a year ago. Gross margin expanded 310bps to 32.6%, aided by a $2.8M MV-75 catch-up but partially offset by $1.7M in higher tariffs. Adjusted operating margin was 12.8%, up 180bps. Management expects continued margin expansion in H2 2026 on volume leverage and lower litigation costs.
Key Risks
Management flagged the Iran War conflict as a potential risk but has seen no impact so far. Tariffs increased $1.7M year-over-year. Rising fuel prices could pressure low-cost carriers (not major customers). Memory chip price squeeze is affecting some products. Delay in the Army Radio Test Program award would affect H2 revenue.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-11
Record Q2 results featured all-time highs in revenue, profit, bookings, and backlog, with adjusted EBITDA margin nearing 20%. Raised full-year revenue guidance to $1.02–$1.04 billion, driven by strong aerospace and test systems performance and robust market demand.
Q1 2026 Q1 2026 2026-05-12
Q1 2026 delivered strong revenue and margin growth, record bookings, and a raised full-year outlook, driven by broad-based demand in aerospace and test systems. Backlog and book-to-bill ratios reached all-time highs, with no current impact from geopolitical conflicts.
Q4 2025 Q4 2025 2026-02-24
Record Q4 revenue and margins capped a strong year, with 2025 adjusted operating margin up to 12.2% and robust cash flow. 2026 guidance calls for 12.5%–15% revenue growth, continued margin expansion, and strong demand in aerospace and test systems.
Q3 2025 Q3 2025 2025-11-04
Revenue reached $211.4 million, with strong margins and cash flow, driven by broad demand and operational improvements. Backlog remains high, and acquisitions plus refinancing actions have enhanced capabilities and reduced dilution risk. Q4 and 2026 are expected to see significant growth.
Q2 2025 Q2 2025 2025-08-06
Second quarter sales rose 3.3% year-over-year, led by record aerospace results, while test segment performance was impacted by a $6.8 million adjustment. 2025 revenue guidance was raised to $840–$860 million, with strong aerospace momentum and improved margins expected to drive a robust second half.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.